With its ability to control hunger, regulate blood sugar levels, reduce inflammation, and improve cardiovascular health, semaglutide has the potential to transform lives for the better
If this trial is successful, we will have the evidence necessary to show the medical community that obesity is a reversible risk factor for atherosclerotic cardiovascular disease and other outcomes, he says
In the pivotal SURMOUNT-1 trial involving adults without diabetes, participants receiving the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% with placebo
Patients with diagnostic codes for giant cell arteritis were excluded
Individuals with underlying gastrointestinal conditions may experience more pronounced symptoms and should consult healthcare providers before initiating supplementation
The curriculum seems to have such ground-breaking suggestions as physical activity is good for you and you should get enough sleep